Copper-Catalyzed Cascade Reactions of Substituted 4-Iodopyrazolecarbaldehydes
1H NMR (300 MHz, CDCl3): d=7.26–7.37 (m, 14H), 7.84 (s,
1H), 10.13 (brs, 1H); 13C NMR (50 MHz, CDCl3 +DMSO-
d6): d=106.6, 122.0, 125.2, 127.7, 128.3, 128.6, 129.4, 139.4,
144.0, 144.4, 146.3; ESI-MS: m/z=337 [M+H]+; DART-
HR-MS: m/z=337.1450, calcd. for C22H17N4 [MH]+:
337.1453.
[2] A few citations only a) A. M. Youssef, M. S. White, E. B.
Villanueva, I. M. El-Ashmawy, A. Klegeris, Bioorg.
Med. Chem. 2010, 18, 2019–2028; b) R. R. Ranatunge,
M. Augustyniak, U. K. Bandarage, R. A. Earl, J. L. Ellis,
D. S. Garvey, D. R. Janero, L. G. Letts, A. M. Martino,
M. G. Murty, S. K. Richardson, J. D. Schroeder, M. J.
Shumway, S. W. Tam, A. M. Trocha, D. V. Young, J.
Med. Chem. 2004, 47, 2180–2193; c) S. Howard, V. Ber-
dini, J. A. Boulstridge, M. G. Carr, D. M. Cross, J. Curry,
L. A. Devine, T. R. Early, L. Fazal, A. L. Gill, M. Heath-
cote, S. Maman, J. E. Matthews, R. L. McMenamin, E. F.
Navarro, M. A. OꢂBrien, M. OꢂReilly, D. C. Rees, M.
Reule, D. Tisi, G. Williams, M. Vinkovic, P. G. Wyatt, J.
Med. Chem. 2009, 52, 379–388; d) S. Lian, H. Su, B.-X.
Zhao, W.-Y. Liu, L.-W. Zheng, J.-Y. Miao, Bioorg. Med.
Chem. 2009, 17, 7085–7092; e) B. Insuasty, A. Tigreros,
F. Orozco, J. Quiroga, R. Abonia, M. Nogueras, A. San-
chez, J. Cobo, Bioorg. Med. Chem. 2010, 18, 4965–4974;
f) Z. K. Sweeney, S. F. Harris, N. Arora, H. Javanbakht,
Y. Li, J. Fretland, J. P. Davidson, J. R. Billedeau, S. K.
Gleason, D. Hirschfeld, J. J. Kennedy-Smith, T. Mirzade-
gan, R. Roetz, M. Smith, S. Sperry, J. M. Suh, J. Wu, S.
Tsing, A. G. Villasenor, A. Paul, G. Su, G. Heilek, J. Q.
Hang, A. S. Zhou, J. A. Jernelius, F. J. Zhang, K.
Klumpp, J. Med. Chem. 2008, 51, 7449–7458; g) D.-J.
Wang, L. Fan, C.-Y. Zheng, Z.-D. Fang, J. Fluorine
Chem. 2010, 131, 584–586; h) R. Venkat Ragavan, V.
Vijayakumar, N. S. Kumari, Eur. J. Med. Chem. 2010, 45,
1173–1180; i) A. Tanitame, Y. Oyamada, K. Ofuji, M.
Fujimoto, N. Iwai, Y. Hiyama, K. Suzuki, H. Ito, H. Ter-
auchi, M. Kawasaki, K. Nagai, M. Wachi, J.-i. Yamagishi,
J. Med. Chem. 2004, 47, 3693–3696; j) C.-H. Wu, M.-S.
Hung, J.-S. Song, T.-K. Yeh, M.-C. Chou, C.-M. Chu, J.-J.
Jan, M.-T. Hsieh, S.-L. Tseng, C.-P. Chang, W.-P. Hsieh,
Y. Lin, Y.-N. Yeh, W.-L. Chung, C.-W. Kuo, C.-Y. Lin,
H.-S. Shy, Y.-S. Chao, K.-S. Shia, J. Med. Chem. 2009, 52,
4496–4510.
General Procedure for Pyrazole-Annulated Benz-
oxazepines as Exemplified for the Synthesis of 2,3-
Diphenyl-2H-pyrazoloACTHNUTRGENNG[U 4,3-b]ACHUTNGTRENN[NGU 1,5]benzoxazepine
To a solution of 4-iodo-1,5-diphenyl-1H-pyrazole-3-carbal-
dehyde (200 mg, 0.53 mmol) in toluene (10 mL), Cs2CO3
(348 mg, 1.07 mmol), CuI (10 mg, 0.053 mmol) and 1,10-phe-
nanthroline (19 mg, 0.107 mmol) were added and the reac-
tion mixture was heated at 908C for 24 h under a nitrogen
atmosphere. Thereafter, water and ethyl acetate were added
and the reaction mass was pass through a Celite bed and the
layers were separated. The aqueous layer was further ex-
tracted with ethyl acetate (2ꢁ20 mL) and the collected or-
ganic layer was washed with brine, dried over anhydrous
Na2SO4 and concentrated under vacuum. Column chroma-
tography of the crude product over silica gel furnished the
pure 2,3-diphenyl-2H-pyrazoloACHTUNTGRENNUG[4,3-b]ACHTUNGTERN[NUGN 1,5]benzoxazepine as
a white solid (ethyl acetate/hexanes, 1:20); yield: 130 mg
(72%).
2,3-Diphenyl-2H-pyrazoloACHTNUTRGENN[UG 4,3-b]HCATUNGTRENN[UGN 1,5]benzoxazepine
(Table 4, entry 1): Mp 169–1708C; Rf =0.34 (hexanes:
1
EtOAc, 90:10, v/v); H NMR (200 MHz, CDCl3): d=7.26–
7.29 (m, 13H), 7.64 (dd, J=3.2 and 5.9 Hz, 1H), 7.81 (dd,
J=3.2 and 5.9 Hz, 1H); 13C NMR (50 MHz, CDCl3): d=
108.5, 111.1, 120.3, 124.8, 125.5, 125.8, 128.5, 128.8, 129.0,
129.2, 129.7, 139.7, 141.4, 141.9, 145.2, 150.7, 158.3; ESI-MS:
m/z=338 [M+H]+; DART-HR-MS: m/z=338.1302, calcd.
for C22H16N3O [MH]+: 338.1293.
Supporting Information
Characterization data for the remaining products and copies
[3] a) L. Yet, Five-Membered Ring Systems: With More than
One N Atom, in: Progress in Heterocyclic Chemistry,
(Eds.: G. W. Gribble, J. A. Joule), Elsevier, 2009, Vol.
21, pp 224–260; b) S. Fustero, A. Simon-Fuentes, J. F.
Sanz-Cervera, Org. Prep. Proced. Int. 2009, 41, 253–290.
[4] M. Schnurch, R. Flasik, A. F. Khan, M. Spina, M. D. Mi-
hovilovic, P. Stanetty, Eur. J. Org. Chem. 2006, 3283–
3307.
1
of H and 13C NMR spectra are available in the Supporting
Information.
Acknowledgements
One of the authors (MN) gratefully acknowledges the finan-
cial support from Council of Scientific and Industrial Re-
search, New Delhi in the form of fellowship. The Sophisticat-
ed Analytical Instrumentation Facility division, CDRI is
gratefully acknowledged for providing the spectral and ana-
lytical data.
[5] S. Nag, M. Nayak, S. Batra, Adv. Synth. Catal. 2009, 351,
2715–2723, and references cited therein.
[6] a) J. T. Reeves, D. R. Fandrick, Z. Tan, J. J. Song, H.
Lee, N. K. Yee, C. H. Senanayake, J. Org. Chem. 2010,
75, 992–994; b) Q. Cai, Z. Li, J. Wei, L. Fu, C. Ha, D.
Pei, K. Ding, Org. Lett. 2010, 12, 1500–1503; c) B.-W.
Zhou, J.-R. Gao, D. Jiang, J.-H. Jia, Z.-P. Yang, H.-W.
Jin, Synthesis 2010, 2794–2798.
[7] D. Ma and Q. Cai, Acc. Chem. Res. 2008, 41, 4150–4160,
and references cited therein.
[8] M. Wolter, G. Nordmann, G. E. Job, S. L. Buchwald,
Org. Lett. 2002, 4, 973–976.
References
[1] L. Yet, in: Comprehensive Heterocyclic Chemistry, Vol.
4, 4.01 (Eds.: A. R. Katrizky, C. A. Ramsden, E. F. V.
Scriven, R. J. K. Taylor), Pergamon, London, 2008,
pp 1–141.
Adv. Synth. Catal. 2010, 352, 3431 – 3437
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3437